Catalyst Wire Dossier Catalyst Wire Dossier

Panadol Baby and Infant 24 mg/mL paracetamol oral suspension

paracetamol · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Panadol Baby and Infant 24 mg/mL paracetamol oral suspension, covering 2024-02-20 to 2024-02-20. Get the full timeline:

Most recent: Clinical Trial Update: A Bioequivalence Study of a New Paracetamol Oral Suspension 24mg/ml Compared to the Marketed Paracetamol Oral Suspension (Panadol Baby and Infant 24mg/ml) in Healthy Adult Subjects [Phase 1]

See pricing